<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146990">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01186913</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT RDCRN PIDTC-6901</org_study_id>
    <nct_id>NCT01186913</nct_id>
    <nct_alias>NCT02108067</nct_alias>
  </id_info>
  <brief_title>Natural History Study of SCID Disorders</brief_title>
  <official_title>A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children With SCID Disorders (RDCRN PIDTC-6901)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Office of Rare Diseases (ORD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      People with Primary Immune Deficiency (PID) may develop severe, life-threatening infections
      as a result of inherited defects in the genes that normally instruct blood-forming cells to
      develop and to fight infections. PID diseases include Severe Combined Immune Deficiency
      (SCID), leaky SCID, Omenn syndrome (OS), and Reticular Dysgenesis (RD). PIDs may be treated
      by transplantation of bone marrow stem cells from a healthy person or, in some cases, by
      enzyme replacement or by gene therapy. Patients with SCID were among the first to receive
      bone marrow stem cell (also called hematopoietic cells) transplantation (HCT) more than 40
      years ago, and HCT is the standard treatment today for this group of diseases. Since PID
      diseases are rare, there are not enough patients at any single center to determine the full
      range of causes, natural history, or best methods of treatment. For this research study many
      PID centers across North America have organized into the Primary Immune Deficiency Treatment
      Consortium (PIDTC) to pool their experience and study PIDs together. The overall goal of
      this study is the prospective evaluation of children with SCID and related disorders who are
      treated under a variety of protocols at participating institutions. The study aims to
      identify variables contributing to the best outcomes for HCT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival following HCT</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Full T cell reconstitution</measure>
    <time_frame>6 months post HCT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full T cell reconstitution</measure>
    <time_frame>12 months post HCT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full T cell reconstitution</measure>
    <time_frame>24 months post HCT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full B cell reconstitution</measure>
    <time_frame>12 months post HCT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full B cell reconstitution</measure>
    <time_frame>24 months post HCT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engraftment</measure>
    <time_frame>100 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engraftment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engraftment</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engraftment</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infections</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth and Nutrition</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft versus Host Disease</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of autoimmunity requiring treatment</measure>
    <time_frame>Throughout the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopment/Neurocognition</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications of HCT needing treatment</measure>
    <time_frame>Throughout the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">265</enrollment>
  <condition>SCID</condition>
  <condition>Leaky SCID</condition>
  <condition>Omenn Syndrome</condition>
  <condition>Reticular Dysgenesis</condition>
  <condition>ADA Deficiency</condition>
  <condition>XSCID</condition>
  <arm_group>
    <arm_group_label>Classic SCID (Stratum A)</arm_group_label>
    <description>Patients with classic SCID after allogeneic hematopoietic stem cell transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Leaky SCID, Omenn syndrome, or RS (Stratum B)</arm_group_label>
    <description>Patients with leaky SCID, Omenn syndrome, or Reticular Dysgenesis (RS) after allogeneic hematopoietic stem cell transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADA Deficiency or XSCID treated with PEG-ADA (Stratum C)</arm_group_label>
    <description>Patients with ADA Deficiency or XSCID who are treated with PEG-ADA (patients with ADA Deficiency) or patients who are treated with gene therapy (ADA Deficiency or XSCID)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosis of SCID or SCID variants treated at Consortium Centers from
        1968-2010
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stratum A, Classic SCID Patients who meet the following inclusion criteria and the
             intention is to treat with allogeneic hematopoietic cell transplant (HCT) are
             eligible for enrollment into Stratum A - Absence or very low number (&lt; 300 / ul) of T
             cells, AND no or very low (&lt;10% of lower limit of normal) T cell function (as
             measured by response to phytohemagglutinin OR T cells of maternal origin present, but
             with &lt;10% of lower limit of normal T cell function (as measured by response to PHA)

        Stratum B, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis Patients who meet the
        following criteria and the intention is to treat with HCT are eligible for enrollment into
        Stratum B-

        Leaky SCID:

          -  &lt;1000 / ul T cell number at &lt; age 2 years; &lt; 800 / ul T cell number at age 2 through
             &lt; 4 years; &lt; 600 / ul at &gt; 4 years; and maternal lymphocytes not detected, AND either
             one or both of the following with rule-out of MHC Class I or II non-expression by
             flow cytometry (or histology):

               1. ≥ 10% and ≤ 30% of lower limit of normal T cell function (as measured by
                  response to PHA), b) Absent proliferative responses to candida and tetanus
                  toxoid antigens (post vaccination or exposure), with expression of HLA by
                  flow/serology

                  Omenn Syndrome:

          -  Generalized skin rash

          -  Maternal lymphocytes not detected

          -  Absent or low (&lt; 30% lower limit of normal) T cell proliferation to antigens

          -  &gt; 80% of CD4 T cells are CD45RO+ (&lt; 2 years of age)

        Reticular Dysgenesis:

          -  &lt; 300 / ul T cell number

          -  None or &lt; 10% lower limit of normal PHA proliferation

          -  Sensori-neural deafness

          -  Severe neutropenia (&lt; 200 / uL and unresponsive to G-CSF) and deficiency of marrow
             granulopoiesis unless there is known adenylate kinase 2 (AK2) pathogenic mutation(s)
             identified

        Stratum C, SCID with Non-HCT Treatments Patients who meet the following criteria and the
        intention is to treat with PEG-ADA or gene transfer with autologous modified cells are
        eligible for enrollment into Stratum C:

          -  ADA Deficient SCID with intention to treat with PEG-ADA

          -  ADA Deficient SCID with intention to treat with gene transfer

          -  X-linked SCID with intention to treat with gene transfer

        Exclusion Criteria:

          -  Patients who meet any one or more of the following exclusion criteria are
             disqualified from enrollment in Strata A, B, or C of the study:

          -  Presence of an HIV infection (by PCR) or other cause of secondary immunodeficiency.

          -  Presence of DiGeorge syndrome

          -  Most patients with other PIDs such as nucleoside phosphorylase deficiency, ZAP70
             deficiency, CD40 ligand deficiency, NEMO deficiency, XLP, cartilage hair hypoplasia
             or ataxia telangiectasia will not meet the inclusion criteria for Stratum A, B, or C
             above. However, a patient with one of the above may meet the inclusion criteria for
             Stratum B and if so will be included.

          -  MHC Class I and MHC Class II antigen deficiency are specifically excluded.

          -  Metabolic conditions that imitate SCID or related disorders such as folate
             transporter deficiency, severe zinc deficiency, transcobalamin deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Buckley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morton J. Cowan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fredrick Goldman, MD</last_name>
      <phone>205-939-5855</phone>
      <email>fgoldman@peds.uab.edu</email>
    </contact>
    <investigator>
      <last_name>Fredrick Goldman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberta Adams, MD</last_name>
      <phone>602-933-0920</phone>
      <email>Adams.Roberta@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Roberta Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renna Killen, RN</last_name>
      <phone>323-361-2217</phone>
      <email>rkillen@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Neena Kapoor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095-1752</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theodore Moore, MD</last_name>
      <phone>310-825-6708</phone>
      <email>TBMoore@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Theodore Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-1278</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Dunn, MA</last_name>
      <phone>415-502-0203</phone>
      <email>Elizabeth.Dunn@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Morton Cowan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Porteus, MD</last_name>
      <phone>650-725-6520</phone>
      <email>mporteus@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Porteus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Craddock, MD</last_name>
      <phone>720-777-3328</phone>
      <email>John.Craddock@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Ralph Quinoes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alfred I. duPont Hospital for Children/Nemours</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emi Caywood, MD</last_name>
      <phone>302-651-5500</phone>
      <email>Emi.caywood@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Emy Caywood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010-2970</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blachy Dávila Dávila Saldaña, MD</last_name>
      <phone>(202)476-4561</phone>
      <email>Bjdavilas1@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Blachy Dávila Saldaña, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>All Children's Hospital, St. Petersburg FL</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksandra Petrovic, MD</last_name>
      <phone>727-767-6856</phone>
      <email>Aleksandra.Petrovic@allkids.org</email>
    </contact>
    <investigator>
      <last_name>Aleksandra Petrovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta/Emory University School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Stenger, MD</last_name>
      <phone>404-785-1272</phone>
      <email>Elizabeth.Stenger@choa.org</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Stenger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morris Kletzel, MD</last_name>
      <phone>773-880-4598</phone>
      <email>MKletzel16@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Morris Kletzel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital/Louisiana State University Health Sciences Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lolie Yu, MD</last_name>
      <phone>504-896-9740</phone>
      <email>lyu@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Lolie Yu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NIH Clinical Center Genetic Immunotherapy Section</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Kang, MD</last_name>
      <phone>301-402-7567</phone>
      <email>ekang@niaid.nih.gov</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung-Yun Pai, MD</last_name>
      <phone>617-919-2508</phone>
      <email>sung-yun.pai@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Sung-Yun Pai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Connelly, MD</last_name>
      <phone>737-936-4000</phone>
      <email>jaconnel@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>James Connelly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Smith, MD</last_name>
      <phone>612-626-2778</phone>
      <email>smith719@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Angie Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Hospital</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Bram, MD</last_name>
      <phone>507-284-2695</phone>
      <email>Bramr@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Bram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Medical Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Sanders, RN</last_name>
      <phone>314-268-2700</phone>
      <phone_ext>3513</phone_ext>
      <email>Wendy_Sanders@ssmhc.com</email>
    </contact>
    <investigator>
      <last_name>Alan Knutsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University St Louis Children's Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shalini Shenoy, MD</last_name>
      <phone>314-454-6018</phone>
      <email>shenoy@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Shalini Shenoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfred Gillio, MD</last_name>
      <phone>201-996-5645</phone>
      <email>AGillio@HackensackUMC.org</email>
    </contact>
    <investigator>
      <last_name>Alfred Gillio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Bhatia, MD</last_name>
      <phone>212-305-9138</phone>
      <email>mb2476@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Monica Bhatia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard J O'Reilly</last_name>
      <phone>212-639-5957</phone>
      <email>oreillyr@mskc.org</email>
    </contact>
    <investigator>
      <last_name>Richard J O'Reilly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center/ Golisano Children's Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Andolina, MD</last_name>
      <phone>585-276-3229</phone>
      <email>Jeffrey_andolina@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Andolina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Medical College, Maria Fareri Children's Hospital</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cori Abikoff, MD</last_name>
      <phone>914-594-2130</phone>
      <email>Cori_Abikoff@nymc.edu</email>
    </contact>
    <investigator>
      <last_name>Cori Abikoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Buckley, MD</last_name>
      <phone>919-684-2922</phone>
      <email>buckl003@mc.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Rebecca Buckley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharat Chandra, MD</last_name>
      <phone>513-636-5917</phone>
      <email>Sharat.Chandra@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Sharat Chandra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rainbow Babies/ University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanjay Ahuja, MD</last_name>
      <phone>216-844-3345</phone>
      <email>Sanjay.Ahuja@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Sanjay Ahuja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolla Abu-arja, MD</last_name>
      <phone>614-722-3582</phone>
      <email>Rolla.abu-arja@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Rolla Abu-arja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-3098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evan Shereck, MD</last_name>
      <phone>503-494-0829</phone>
      <email>Shereck@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Evan Shereck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Sullivan, MD, PhD</last_name>
      <phone>215-590-1697</phone>
      <email>sullivak@mail.med.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Kathleen Sullivan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMC</name>
      <address>
        <city>Pittsburg</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark T. Vander Lugt, MD</last_name>
      <phone>412-692-7035</phone>
      <email>mark.vanderlugt@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Mark T. Vander Lugt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center/Children's of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Aquino, MD</last_name>
      <phone>214-648-8800</phone>
      <email>victor.aquino@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Victor Aquino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-2399</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chivon McMullen-Jackson, RN, BSN</last_name>
      <phone>832-824-1339</phone>
      <email>cdmcmull@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>William Shearer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Children's Hospital of South Texas/Texas Transplant Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Troy Quigg, MD</last_name>
      <phone>210-575-7348</phone>
      <email>Troy.Quigg@MHShealth.com</email>
    </contact>
    <investigator>
      <last_name>Troy Quigg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Primary Children's Medical Center/University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Boyer, MD</last_name>
      <phone>801-662-4830</phone>
      <email>Michael.boyer@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Boyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauri M Burroughs, MD</last_name>
      <phone>206-667-2396</phone>
      <email>lburroug@fhcrc.org</email>
    </contact>
    <investigator>
      <last_name>Lauri M Burroughs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin/ American Family Children's Hospital</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705-2275</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth DeSantes, MD</last_name>
      <phone>608-263-8563</phone>
      <email>kbdesantes@pediatrics.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Kenneth DeSantes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226-4874</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica S Thakar, MD</last_name>
      <phone>414-266-6848</phone>
      <email>mthakar@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Monica S Thakar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Davis, MD</last_name>
      <phone>604-875-3577</phone>
      <email>jdavis@cw.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cancer Care Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geoff Cuvelier, MD</last_name>
      <phone>204-787-8689</phone>
      <email>geoff.cuvelier@cancercare.mb.ca</email>
    </contact>
    <investigator>
      <last_name>Geoff Cuvelier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU St. Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elie Haddad, MD</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>6217</phone_ext>
      <email>elie.haddad@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Elie Haddad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.niaid.nih.gov/</url>
    <description>National Institute of Allergy and Infectious Diseases (NIAID)</description>
  </link>
  <link>
    <url>http://rarediseasesnetwork.epi.usf.edu/PIDTC/</url>
    <description>Primary Immune Deficiency Treatment Consortium (PIDTC)</description>
  </link>
  <reference>
    <citation>Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, Shearer WT. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008 Dec;122(6):1087-96. doi: 10.1016/j.jaci.2008.09.045. Epub 2008 Nov 6.</citation>
    <PMID>18992926</PMID>
  </reference>
  <results_reference>
    <citation>Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, Goldman F, Kapoor N, Small T, Smith A, Chan KW, Cuvelier G, Heimall J, Knutsen A, Loechelt B, Moore T, Buckley RH. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013 Oct;33(7):1156-64. doi: 10.1007/s10875-013-9917-y. Epub 2013 Jul 2.</citation>
    <PMID>23818196</PMID>
  </results_reference>
  <results_reference>
    <citation>Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014 Apr;133(4):1092-8. doi: 10.1016/j.jaci.2013.09.044. Epub 2013 Nov 28.</citation>
    <PMID>24290292</PMID>
  </results_reference>
  <results_reference>
    <citation>Haddad E, Allakhverdi Z, Griffith LM, Cowan MJ, Notarangelo LD. Survey on retransplantation criteria for patients with severe combined immunodeficiency. J Allergy Clin Immunol. 2014 Feb;133(2):597-9. doi: 10.1016/j.jaci.2013.10.022. Epub 2013 Dec 10.</citation>
    <PMID>24331379</PMID>
  </results_reference>
  <results_reference>
    <citation>Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, Cant AJ, Chatila T, Cunningham-Rundles C, Dinauer MC, Dvorak CC, Filipovich AH, Fleisher TA, Bobby Gaspar H, Gungor T, Haddad E, Hovermale E, Huang F, Hurley A, Hurley M, Iyengar S, Kang EM, Logan BR, Long-Boyle JR, Malech HL, McGhee SA, Modell F, Modell V, Ochs HD, O'Reilly RJ, Parkman R, Rawlings DJ, Routes JM, Shearer WT, Small TN, Smith H, Sullivan KE, Szabolcs P, Thrasher A, Torgerson TR, Veys P, Weinberg K, Zuniga-Pflucker JC; workshop participants.. Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol. 2014 Feb;133(2):335-47. doi: 10.1016/j.jaci.2013.07.052. Epub 2013 Oct 15.</citation>
    <PMID>24139498</PMID>
  </results_reference>
  <results_reference>
    <citation>Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Shearer WT, Burroughs LM, Torgerson TR, Decaluwe H, Haddad E; workshop participants.. Primary Immune Deficiency Treatment Consortium (PIDTC) update. J Allergy Clin Immunol. 2016 Aug;138(2):375-85. doi: 10.1016/j.jaci.2016.01.051. Epub 2016 Apr 22.</citation>
    <PMID>27262745</PMID>
  </results_reference>
  <results_reference>
    <citation>Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014 Jul 31;371(5):434-46. doi: 10.1056/NEJMoa1401177.</citation>
    <PMID>25075835</PMID>
  </results_reference>
  <results_reference>
    <citation>Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT; Workshop Participants.. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009 Dec;124(6):1152-60.e12. doi: 10.1016/j.jaci.2009.10.022.</citation>
    <PMID>20004776</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 26, 2016</lastchanged_date>
  <firstreceived_date>August 20, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Severe Combined Immunodeficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
